BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 29664841)

  • 1. Three-Year Recurrence-Free Survival in Patients With a Very Low Risk of Endometrial Cancer Who Did Not Undergo Lymph Node Dissection (Tree Retro): A Korean Multicenter Study.
    Kim M; Choi C; Kim K; Lim MC; Park JY; Hong JH; Lee M; Paek J; Seoung J; Lee S; Lee TS
    Int J Gynecol Cancer; 2018 Jul; 28(6):1123-1129. PubMed ID: 29664841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival impact based on the thoroughness of pelvic lymphadenectomy in intermediate- or high-risk groups of endometrioid-type endometrial cancer: A multi-center retrospective cohort analysis.
    Kim TH; Kim HS; Kim TJ; Chang SJ; Kim DY; Ryu SY; Kim BG; Kim YT; Bae DS; Ryu HS; Nam JH
    Gynecol Oncol; 2016 Jun; 141(3):440-446. PubMed ID: 27020700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes and relapse patterns of stage IB grade 2 or 3 endometrial cancer treated with adjuvant vaginal brachytherapy.
    Hochreiter A; Kelly JR; Young MR; Litkouhi B; Black JD; Stromberger C; Higgins S; Schwartz PE; Damast S
    Int J Gynecol Cancer; 2020 Jan; 30(1):48-55. PubMed ID: 31722964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is Surgical Staging Necessary for Patients with Low-risk Endometrial Cancer? A Retrospective Clinical Analysis.
    Kokcu A; Kurtoglu E; Celik H; Kefeli M; Tosun M; Onal M
    Asian Pac J Cancer Prev; 2015; 16(13):5331-5. PubMed ID: 26225674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative identification of a low-risk group for lymph node metastasis in endometrial cancer: a Korean gynecologic oncology group study.
    Kang S; Kang WD; Chung HH; Jeong DH; Seo SS; Lee JM; Lee JK; Kim JW; Kim SM; Park SY; Kim KT
    J Clin Oncol; 2012 Apr; 30(12):1329-34. PubMed ID: 22412131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is lymph node dissection mandatory among early stage endometrial cancer patients? A retrospective study.
    Zhang G; Chen H; Liu Y; Niu L; Jin L; Li D; Song L; Shang L; Lin X; Wang F; Li F; Zhang X; Zhang X; Gao Y; Qiu D; Zhang Y; Na R; Su R
    BMC Womens Health; 2020 Nov; 20(1):258. PubMed ID: 33213444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pelvic lymphadenectomy as alternative to postoperative radiotherapy in high risk early stage endometrial cancer.
    Papanikolaou A; Kalogiannidis I; Goutzioulis M; Misailidou D; Makedos A; Vergote I; Makedos G
    Arch Gynecol Obstet; 2006 May; 274(2):91-6. PubMed ID: 16518607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncologic Outcomes After Adjuvant Radiotherapy for Stage II Endometrial Carcinoma: A Korean Radiation Oncology Group Study (KROG 14-10).
    Jung J; Kim YS; Joo JH; Park W; Lee JH; Kim JH; Yoon WS; Lee SH; Eom KY; Kim YB
    Int J Gynecol Cancer; 2017 Sep; 27(7):1387-1392. PubMed ID: 28604455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant Treatment after Surgery in Stage IIIA Endometrial Adenocarcinoma.
    Yoon MS; Huh SJ; Kim HJ; Kim YS; Kim YB; Kim JY; Lee JH; Kim HJ; Cha J; Kim JH; Kim J; Yoon WS; Choi JH; Chun M; Choi Y; Lee KK; Kim M; Jeong JU; Chang SK; Park W
    Cancer Res Treat; 2016 Jul; 48(3):1074-83. PubMed ID: 26511800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FIGO stage IIIC endometrial carcinoma: prognostic factors and outcomes.
    Hoekstra AV; Kim RJ; Small W; Rademaker AW; Helenowski IB; Singh DK; Schink JC; Lurain JR
    Gynecol Oncol; 2009 Aug; 114(2):273-8. PubMed ID: 19428094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of endometrial carcinoma in young women at a high-volume cancer center.
    Biler A; Solmaz U; Erkilinc S; Gokcu M; Bagci M; Temel O; Karadeniz T; Sanci M
    Int J Surg; 2017 Aug; 44():185-190. PubMed ID: 28673864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Survival, prognostic factors and modern tendencies in adjuvant treatment of diagnosed endometrial cancer patients with or without lymph node dissection].
    Ivanov I
    Akush Ginekol (Sofiia); 2009; 48 Suppl 1():3-11. PubMed ID: 20387272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of prognostic value of lymphovascular space invasion in patients with endometrial cancer and negative sentinel lymph nodes.
    Matanes E; Eisenberg N; Lau S; Salvador S; Ferenczy A; Pelmus M; Gotlieb WH; Kogan L
    Gynecol Oncol; 2021 Aug; 162(2):256-261. PubMed ID: 34119364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of tumor volume in endometrial cancer: a Japan-Korea cooperative study.
    Todo Y; Choi HJ; Kang S; Kim JW; Nam JH; Watari H; Tamakoshi A; Sakuragi N
    Gynecol Oncol; 2013 Nov; 131(2):294-8. PubMed ID: 23954595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term survival in patients with para-aortic lymph node metastasis with systematic retroperitoneal lymphadenectomy followed by adjuvant chemotherapy in endometrial carcinoma.
    Hiura M; Nogawa T; Matsumoto T; Yokoyama T; Shiroyama Y; Wroblewski J
    Int J Gynecol Cancer; 2010 Aug; 20(6):1000-5. PubMed ID: 20683408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase III randomized clinical trial comparing sentinel node biopsy with no retroperitoneal node dissection in apparent early-stage endometrial cancer - ENDO-3: ANZGOG trial 1911/2020.
    Obermair A; Nicklin J; Gebski V; Hayes SC; Graves N; Mileshkin L; Lin MY; Beale P; Baxter E; Robledo K; Salomon C; Hanna GB; Janda M
    Int J Gynecol Cancer; 2021 Dec; 31(12):1595-1601. PubMed ID: 34728527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of lymphadenectomy in intermediate-risk endometrial cancer: a matched-pair study.
    Coronado PJ; Rychlik A; Martínez-Maestre MA; Baquedano L; Fasero M; García-Arreza A; Morales S; Lubian DM; Zapardiel I
    J Gynecol Oncol; 2018 Jan; 29(1):e1. PubMed ID: 29185259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of wide/radical hysterectomy and pelvic lymph node dissection in endometrial cancer with cervical involvement.
    Mariani A; Webb MJ; Keeney GL; Calori G; Podratz KC
    Gynecol Oncol; 2001 Oct; 83(1):72-80. PubMed ID: 11585416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology.
    Lutman CV; Havrilesky LJ; Cragun JM; Secord AA; Calingaert B; Berchuck A; Clarke-Pearson DL; Soper JT
    Gynecol Oncol; 2006 Jul; 102(1):92-7. PubMed ID: 16406063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors associated with survival after relapse in patients with low-risk endometrial cancer treated with surgery alone.
    Topfedaisi Ozkan N; Meydanlı MM; Sarı ME; Demirkiran F; Kahramanoglu I; Bese T; Arvas M; Şahin H; Haberal A; Celik H; Coban G; Oge T; Yalcin OT; Akbayır Ö; Erdem B; Numanoğlu C; Özgül N; Boyraz G; Salman MC; Yüce K; Dede M; Yenen MC; Taşkın S; Altın D; Ortaç UF; Aydın Ayık H; Şimşek T; Güngör T; Güngördük K; Sancı M; Ayhan A
    J Gynecol Oncol; 2017 Sep; 28(5):e65. PubMed ID: 28657226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.